cancer clinical trials for Lymphoma/CLL (ONC)

19 Lymphoma/CLL (ONC) clinical trials found. View a list of all cancer clinical trial types.

• Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma (EPCORE FL-2)

  Current Status: Not Open

  View links and contact information related to this clinical trial

• Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1B/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide Plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• An open-label phase II study to investigate the efficacy, safety, and pharmacokinetics of tirabrutinib in patients with Primary Central Nervous System Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A First-In-Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1 study evaluating SC291, a hypoimmune allogeneic CD19-directed CAR T cell therapy, in relapsed and/or refractory B-cell malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1, Open-label Study to Evaluate SGN-35C in Adults With Advanced Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

  Current Status: Open

  View links and contact information related to this clinical trial

• FT522-101: A Phase 1 Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory BCell Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  Current Status: Open

  View links and contact information related to this clinical trial

• Long-term Follow-up Protocol For Subjects Treated with Gene-modified T Cells

  Current Status: Open

  View links and contact information related to this clinical trial

• An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)

  Current Status: Open

  View links and contact information related to this clinical trial

• Low Dose Radiation as Bridging Therapy for Lisocabtagene Maraleucel in Relapsed B-Cell Non-Hodgkin Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Pilot, Randomized, Double-blind, Placebo-controlled Study using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation in Multiple Myeloma and Lymphoma: The PRIMAL Trial

  Current Status: Open

  View links and contact information related to this clinical trial